Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05DBZ
|
|||
| Former ID |
DND000020
|
|||
| Drug Name |
AGS-8M4
|
|||
| Synonyms |
AGS-8 MAb, Agensys, AGS8M4, ASP-6183
Click to Show/Hide
|
|||
| Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Discontinued in Phase 2 | [1], [2] | |
| Company |
Astellas
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | R&D Pipeline (February 2011). | |||
| REF 2 | ClinicalTrials.gov (NCT00816764) A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.